Copyright
©The Author(s) 2023.
World J Clin Pediatr. Mar 9, 2023; 12(2): 45-56
Published online Mar 9, 2023. doi: 10.5409/wjcp.v12.i2.45
Published online Mar 9, 2023. doi: 10.5409/wjcp.v12.i2.45
Table 1 Demographic characteristics of survey respondents
| Parameters | Parents of IBD patients (n = 51) | Parents of JIA patients (n = 81) | Parents of HC (n = 58) | P value |
| Patients characteristics | ||||
| Age of inclusion in the study, years, Me (25%; 75%) | 13.6 (2.7; 17.0) | 7.8 (2.0; 18.0) | 11.3 (3.0; 17.0) | 0.00006 |
| Gender, females, n (%) | 24 (47) | 43 (54) | 28 (49) | 0.0000001 |
| The onset of the disease, years, Me (25%; 75%) | 10.9 (1.0; 17.0) | 4.7 (0.8; 16.0) | NA | 0.0000001 |
| Parental status | ||||
| Gender of representative, females, n (%) | 49 (96.1) | 71 (88.2) | 57 (98.3) | 0.022 |
| Education level, n (%) -secondary school -higher education -academic degree | 18 (36) 33 (64) 0 (0) | 11 (13.6) 66 (81.5) 3 (4.9) | 13 (22.4) 45 (77.6) 0 (0) | 0.019 |
| Level of employment, n (%) -working -self-employed -unemployed -receiving welfare support | 32 (62.7) 5 (9.8) 8 (15.7) 6 (11.8) | 48 (59) 8 (9.9) 12 (14.8) 13 (16,3) | 37 (65) 11(18.5) 9 (16.5) 0 (0) | > 0.050 |
| Family status, n (%) - Married - Divorced - Widow/widower - Single parent | 43 (85.2) 4 (8.6) 1 (1.2) 2 (5) | 66 (80.4) 9 (11.8) 3 (3.9) 3 (3.9) | 46 (79.3) 11 (19.0) 1 (1.7) 0 (0) | 0.327 |
Table 2 Vaccine coverage of survey respondents
| Parameters | Parents of IBD patients (n = 51) | Parents of JIA patients (n = 81) | Parents of HC (n = 58) | P value |
| Vaccine status | ||||
| Completed vaccination according to the national calendar, n (%) | 42 (82.3) | 65 (79.9) | 52 (91.4) | 0.320 |
| Temporary medical contraindications for vaccination (postponed vaccination), n (%) | 9 (17.6) | 14 (17.3) | 2 (3.4) | 0.000001 |
| Refused to be vaccinated, n (%) | 0 (0) | 2 (2.5) | 3 (5.2) | 0.00001 |
| Vaccine-associated reactions: No reaction Fever Injection site reactions | 38 (74.5) 11 (21.6) 2 (3.9) | 41 (50.6) 27 (33.3) 13 (16.1) | 31 (53.5) 14 (24.1) 13 (22.4) | 0.020 |
| Continued vaccination after diagnosis, n (%) | 5 (10.9) | 6 (7.4) | NA | 0.505 |
| Had an opportunity to discuss vaccinations with the attending physician, n (%) | 16 (32) | 23 (28.4) | NA | 0.716 |
| Control of anti-vaccine antibodies before immunosuppressive treatment, n (%) | 22 (43.2) | 24 (29.6) | NA | 0.147 |
| Factors encouraged vaccination, n (%) - Personal beliefs - Doctor's advice - Internet / Media - Parents' forums - Others | 10 (20) 42 (84) 2 (4) 2 (4) 2 (4) | 25 (30.8) 56 (69.1) 8 (9.9) 9.9 (12.3) 5 (6.4) | 40 (70.9) 19 (34.5) 7 (12.7) 1 (1.8) 6 (10.9) | 0.010 |
| Additional vaccines, n (%), against - tick-borne encephalitis - influenza - meningococcus - pneumococcus - varicella | 8 (9.8) 6 (11.7) 8 (16.0) 29 (56.8) 6 (12.7) | 3 (3.7) 9 (11.1) 8 (9.8) 23 (29.4) 7 (6,2) | 8 (14.5) 20 (35.1) 21 (36.8) 27 (48.9) 17 (30.2) | 0.003 0.002 0.0000001 0.000004 0.000002 |
- Citation: Makarova E, Khabirova A, Volkova N, Gabrusskaya T, Ulanova N, Sakhno L, Revnova M, Kostik M. Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data. World J Clin Pediatr 2023; 12(2): 45-56
- URL: https://www.wjgnet.com/2219-2808/full/v12/i2/45.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v12.i2.45